NeoMedica company from Niš offers a unique solution to significantly improve the classic method of conducting ELISA tests. NAISSA Immuno Assay Monotest enables the collection of all the required reagents to perform the test using only one vessel, which, in addition to significantly simplifying the process itself, eliminates oxidation or contamination of the contents. Additionally, it contributes to the reduction of waste materials.
NEOMEDICA: NAISSA Immuno Assay Monotest
Company: NEOMEDICA
Project name: NAISSA Immuno Assay Monotest
Town: Niš
Industry: Medical and therapeutical devices
Project value: EUR 363,717
IF participation: EUR 254,598
Project start: 15.10.2018.
Duration: 21 months
